Provectus Biopharmaceuticals, Inc.

PVCT ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
8-K Jun 20, 2025 8-K
8-K Jun 18, 2025 8-K
DEFA14A Jun 18, 2025 DEFA14A
4 Jun 6, 2025 4
4 May 27, 2025
10-K/A May 16, 2025 10-K/A
4 May 15, 2025
10-Q May 14, 2025
4 May 8, 2025
ARS May 5, 2025 ARS
4 May 2, 2025
DEFA14A May 1, 2025 DEFA14A
DEF 14A May 1, 2025 DEF 14A
4 Apr 30, 2025
4 Apr 21, 2025
PRE 14A Apr 18, 2025
4 Apr 16, 2025
8-K Apr 16, 2025
4 Apr 8, 2025
10-K Mar 28, 2025
4 Mar 26, 2025
4 Mar 21, 2025
4 Mar 21, 2025
4 Feb 27, 2025
4 Feb 21, 2025
← Newer Page 4 of 43 · 1075 filings Older →